{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-097517","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2026-08-17T10:42:37+00:00","discovered_at":"2026-08-17T10:45:00.649814+00:00","generated_at":"2026-08-17T10:45:16.323006+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Accendra Health scraps ATM program, sells non-core assets for $45M, targets CEO successor by mid-September","bullets":["Company will not implement at-the-market equity program; no impact on results or published guidance.","Two non-core asset sales: first closed in Q3, second expected by year-end; ~$45M combined cash in Q3/Q4.","Undrawn on $300M revolving credit facility at end of Q2; confident in liquidity position.","CEO Pesicka to retire by end of 2026; Board expects to name successor by mid-September 2026.","Pesicka remains CEO until successor in place, then advisory role for orderly transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-097517","json":"https://secwatch.observer/filing/0001104659-26-097517.json","markdown":"https://secwatch.observer/filing/0001104659-26-097517.md","text":"https://secwatch.observer/filing/0001104659-26-097517.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000110465926097517/0001104659-26-097517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000110465926097517/tm2622667d5_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T10:45:16.323006+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}